Testing Seralutinib with Gereic Dry Powder Inhaler for pulmonary arterial hypertension
Explore this study →
Sites in Calgary, London and 2 more cities
RecruitingPHASE3
Official title: Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
Pulmonary Arterial Hypertension · Gossamer Bio USA, Inc.